Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet ( 扶正化瘀片) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial
DiscussionThrough this study, we hope to generate a solid evidence for the therapeutic strategy of HBV cirrhosis with a combination of anti-viral such as ETV and anti-fibrotic herbal product such as FZHY. Protocol version: Version 1.3, Date: 2014.12.4. Trial registration number: NCT02241590.
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: China Health | Cirrhosis | Clinical Trials | Complementary Medicine | Headache | Hepatitis | Hepatitis B | Herbs | Internal Medicine | Liver | Migraine | Study | Urology & Nephrology